A 25-year-old multi-organ donor has a heart rate of 104/min and mean arterial pressure of 70 mmHg. What should the Procurement Coordinator do?

A 25-year-old multi-organ donor has a heart rate of 104/min and mean arterial pressure of 70 mmHg. What should the Procurement Coordinator do?

• A. Start vasopressin
• B. Continue the present treatment
• C. Initiate T4 protocol
• D. Give 1L crystalloid bolus over 1 hr

Answer: (B)

In this scenario, the Procurement Coordinator is assessing the hemodynamic status of a 25-year-old multi-organ donor. The heart rate of 104 beats per minute indicates mild tachycardia, while the mean arterial pressure (MAP) of 70 mmHg is within an acceptable range, though on the lower end of normal. The decision to continue current treatment reflects a key aspect of donor management, which is to maintain stable hemodynamics. At this point, there may not be immediate indications to initiate additional interventions or changes in treatment, such as administering vasopressin, starting a T4 protocol, or giving a crystalloid bolus. It's essential to understand that in the context of organ donation, maintaining a stable blood pressure and heart rate is crucial for the viability of the organs for transplantation. While the heart rate is slightly elevated, a MAP of 70 mmHg suggests that the current management may be effectively maintaining perfusion to vital organs, thus preserving organ quality for potential transplant recipients. Assessing ongoing treatment helps ensure that there is no unnecessary use of interventions that may lead to complications or affect the donor status negatively. In conclusion, the recommendation to continue the present treatment is based on the assessment that the donor is stable

In this scenario, the Procurement Coordinator is assessing the hemodynamic status of a 25-year-old multi-organ donor. The heart rate of 104 beats per minute indicates mild tachycardia, while the mean arterial pressure (MAP) of 70 mmHg is within an acceptable range, though on the lower end of normal.

The decision to continue current treatment reflects a key aspect of donor management, which is to maintain stable hemodynamics. At this point, there may not be immediate indications to initiate additional interventions or changes in treatment, such as administering vasopressin, starting a T4 protocol, or giving a crystalloid bolus.

It's essential to understand that in the context of organ donation, maintaining a stable blood pressure and heart rate is crucial for the viability of the organs for transplantation. While the heart rate is slightly elevated, a MAP of 70 mmHg suggests that the current management may be effectively maintaining perfusion to vital organs, thus preserving organ quality for potential transplant recipients. Assessing ongoing treatment helps ensure that there is no unnecessary use of interventions that may lead to complications or affect the donor status negatively.

In conclusion, the recommendation to continue the present treatment is based on the assessment that the donor is stable